Insulin– tag –
-
Rising Costs of CGM and Insulin Pumps Threaten Patient Access to Home Medical Equipment in Diabetes Care: AAHomecare Warns
AAHomecare (via Facebook) America Overview Reports indicate that increasing costs for Continuous Glucose Monitoring (CGM) and insulin pumps are impacting access to diabetes care and home medical equipment. Due to largely stagnant reimbur... -
Senseonics Eversense 365 Receives FDA Approval as World’s First Year-Long Wearable CGM, Expanded Medicare Coverage to Reshape Market
Constancy Researchers America Overview Senseonics' Eversense 365 has secured FDA approval, becoming the world's first commercially available year-long implantable continuous glucose monitor (CGM). This innovation fundamentally improves p... -
Abbott and Medtronic Announce Global Partnership to Integrate FreeStyle Libre CGM Technology into Medtronic Insulin Delivery Systems
Abbott (via Facebook press release), Medtronic USA Overview Medtronic and Abbott have announced a global partnership to integrate Abbott's FreeStyle Libre sensing technology into Medtronic's insulin delivery systems. Under this agreement... -
Dexcom Stelo Wins FDA Approval as First Prescription-Free OTC Continuous Glucose Monitor for Non-Insulin Users
Dexcom (via Facebook) USA Overview Dexcom's Stelo glucose biosensor system has received FDA approval as the first over-the-counter (OTC) continuous glucose monitor (CGM) for adults aged 18 and older who do not use insulin. This landmark ... -
Century Therapeutics Targets Q4 2026 IND Submission for iPSC-Derived CNTY-813 in Type 1 Diabetes, Advances CAR-iT Cell Therapy CNTY-308 Towards Clinical Trials This Year
Century Therapeutics, Inc. (Press Release) USA Overview Century Therapeutics announced that it has completed its pre-IND meeting with the FDA for CNTY-813, an iPSC-derived cell therapy for Type 1 diabetes, targeting an Investigational Ne... -
Chemically Defined, Serum-Free Media Innovations Drive Market Expansion: AuctuCel Launches AI-Powered Medium, Gibco Achieves High CHO Cell Titer
Media City Scientific Singapore Overview Innovations in serum-free and chemically defined media are rapidly advancing, eliminating animal-derived components and boosting reproducibility in cell culture. Qkine launched FRS™ Pioneer, while... -
UnitedHealthcare Updates CGM and Insulin Delivery Coverage Policy: Non-Invasive CGMs Excluded Due to Lack of Evidence
UHC Provider Portal (UnitedHealthcare) USA Overview UnitedHealthcare (UHC) has updated its medical policy regarding coverage for continuous glucose monitoring (CGM) and insulin delivery systems for diabetes management. The updated policy... -
Dexcom Achieves 13% Q2 Revenue Growth as FDA Approves OTC Glucose Biosensor Stelo for Pediatric Use
Medical Design and Outsourcing USA Overview Dexcom reported a robust 13% year-over-year revenue growth in Q2 2026, demonstrating the efficacy of its CGM technology in non-insulin-using Type 2 diabetes patients. Concurrently, the U.S. FDA... -
MIT’s Non-Invasive Raman-Based CGM Achieves Accuracy Comparable to Commercial Devices, Signaling Next-Generation Glucose Monitoring Potential
Morld USA Overview MIT researchers have developed a novel Raman-based non-invasive continuous glucose monitoring (CGM) device that reads glucose through the skin without needles. Initial tests demonstrate accuracy comparable to existing ... -
Medtronic Launches Simplera Sync CGM Sensor in South Korea, Streamlining Glucose Management for MiniMed 780G Users
KBR South Korea Overview Medtronic has launched its Simplera Sync Sensor, a new continuous glucose monitoring (CGM) device, in South Korea for users of the MiniMed 780G automated insulin delivery (AID) system. This all-in-one disposable ...
